{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:08:04Z","timestamp":1770480484145,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jdcr.2025.10.002","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:20:28Z","timestamp":1760145628000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hydroxychloroquine in the treatment of lichen planus-like cutaneous immune-related adverse events"],"prefix":"10.1016","volume":"66","author":[{"given":"Kyle","family":"Mueller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Bogner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew","family":"Kuraitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jdcr.2025.10.002_bib1","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bjd.20698","article-title":"Histopathologically-confirmed lichenoid eruptions from immune checkpoint inhibitor therapy: a retrospective cohort analysis","volume":"185","author":"Jacoby","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdcr.2025.10.002_bib2","unstructured":"Management of immunotherapy-related toxicities. National comprehensive cancer network, Inc. NCCN Clinical Practice Guidelines in Oncology V.1.2025. ICI_Derm-4. Accessed April 14, 2025. To view the most recent and complete version of the guideline, go online to NCCN.org."},{"issue":"31","key":"10.1016\/j.jdcr.2025.10.002_bib3","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1200\/JCO.24.00191","article-title":"Corticosteroids for immune-related adverse events and checkpoint inhibitor efficacy: analysis of six clinical trials","volume":"42","author":"Verheijden","year":"2024","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jdcr.2025.10.002_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7874\/kja.2012.16.2.65","article-title":"Characteristics of adverse effects when using high dose short term steroid regimen","volume":"16","author":"Min","year":"2012","journal-title":"Korean J Audiol"},{"key":"10.1016\/j.jdcr.2025.10.002_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.928390","article-title":"The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy","volume":"12","author":"Bruera","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jdcr.2025.10.002_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdcr.2024.11.010","article-title":"Immunotherapy-associated bullous and oral erosive lichenoid eruption successfully treated with hydroxychloroquine","volume":"56","author":"Alnajjar","year":"2025","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.jdcr.2025.10.002_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cup.13587","article-title":"Pembrolizumab-induced pseudoepitheliomatous eruption consistent with hypertrophic lichen planus","volume":"47","author":"Coscarart","year":"2020","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1016\/j.jdcr.2025.10.002_bib8","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1111\/ajd.14223","article-title":"Nivolumab-induced lichenoid penile ulceration and re-emergent mucocutaneous eruption treated with hydroxychloroquine","volume":"65","author":"Headd","year":"2024","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.10.002_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00403-025-04226-7","article-title":"Hydroxychloroquine is safe and efficacious in oral lichen planus: data from a large outpatient cohort","volume":"317","author":"Abdusalamova","year":"2025","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.jdcr.2025.10.002_bib10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaip.2024.03.034","article-title":"Cutaneous hypersensitivity reactions to immune checkpoint inhibitors","volume":"12","author":"Storgard","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.jdcr.2025.10.002_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/DER.0000000000000776","article-title":"Systemic treatment of cutaneous adverse events after immune checkpoint inhibitor therapy: a review","volume":"34","author":"Brown","year":"2023","journal-title":"Dermatitis"},{"issue":"4","key":"10.1016\/j.jdcr.2025.10.002_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13555-020-00409-4","article-title":"Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature","volume":"10","author":"Balak","year":"2020","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625005168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625005168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:17:30Z","timestamp":1770409050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625005168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":12,"alternative-id":["S2352512625005168"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.10.002","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxychloroquine in the treatment of lichen planus-like cutaneous immune-related adverse events","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}